Equity · Healthcare
LQDA
NASDAQLiquidia Corporation
The line runs $79 on 1 July through $71 on 24 September, on a scale from $60 to $100. Days the market did not trade hold the previous close, flat.
The chart above plots the price of LQDA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 60 sessions over that window: $79 on 1 July 2026 through $71 on 24 September 2026.
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 24, 2026
LQDA insider trades
LQDA has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 16 June 2026.
Showing the 12 most recent of 33 open-market trades in this window. The figures above count all of them.
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 19 compensation filings in this window. The figures above count all of them.
LQDA reported financials
LQDA reported revenue of $158.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$68.9M.
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
LQDA earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
LQDA institutional holders
6 of the 45 institutional funds we track reported a LQDA position for the quarter ended 30 Jun 2026 — a combined $156.4M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
LQDA fails-to-deliver
On 31 Aug 2026, 4,662 shares of LQDA failed to deliver (about $316K).
Source: SEC fails-to-deliver (CNS) data